{
  "patient": {
    "id": "12345",
    "age": 62,
    "sex": "M",
    "birth_date": "1962-03-15"
  },
  "diagnosis": {
    "primary_diagnosis": "Adenocarcinoma polmonare stadio IV",
    "stage": "I",
    "icd_o_code": {
      "code": "8140/3",
      "system": "ICD-O-3",
      "display": "Adenocarcinoma, NOS",
      "topography": "C34"
    }
  },
  "variants": [
    {
      "gene": "EGFR",
      "variant": "p.Leu858Arg",
      "cdna_change": "c.2573T>G",
      "protein_change": "p.Leu858Arg",
      "vaf": 45.0,
      "classification": "Pathogenic",
      "hgnc_code": {
        "code": "HGNC:3236",
        "system": "http://www.genenames.org",
        "name": "Epidermal Growth Factor Receptor",
        "chromosome": "7",
        "cancer_types": [
          "NSCLC",
          "Glioblastoma",
          "Colorectal"
        ],
        "actionable": true
      },
      "clinical_annotation": {
        "variant": "EGFR p.Leu858Arg",
        "actionability": {
          "is_actionable": false,
          "score": 0.0,
          "level": null
        },
        "oncogenicity": {
          "classification": "Unknown",
          "mutation_effect": null
        },
        "therapeutic_options": {
          "fda_approved": [],
          "guideline_recommended": [],
          "investigational": [],
          "resistance": []
        },
        "evidence_sources": [],
        "references": {
          "civic": null,
          "oncokb": "https://www.oncokb.org/gene/EGFR"
        },
        "recommendation": "No high-level evidence for targeted therapy"
      }
    },
    {
      "gene": "EGFR",
      "variant": "p.Thr790Met",
      "cdna_change": "c.2369C>T",
      "protein_change": "p.Thr790Met",
      "vaf": 12.0,
      "classification": "Pathogenic",
      "hgnc_code": {
        "code": "HGNC:3236",
        "system": "http://www.genenames.org",
        "name": "Epidermal Growth Factor Receptor",
        "chromosome": "7",
        "cancer_types": [
          "NSCLC",
          "Glioblastoma",
          "Colorectal"
        ],
        "actionable": true
      },
      "clinical_annotation": {
        "variant": "EGFR p.Thr790Met",
        "actionability": {
          "is_actionable": false,
          "score": 0.0,
          "level": null
        },
        "oncogenicity": {
          "classification": "Unknown",
          "mutation_effect": null
        },
        "therapeutic_options": {
          "fda_approved": [],
          "guideline_recommended": [],
          "investigational": [],
          "resistance": []
        },
        "evidence_sources": [],
        "references": {
          "civic": null,
          "oncokb": "https://www.oncokb.org/gene/EGFR"
        },
        "recommendation": "No high-level evidence for targeted therapy"
      }
    },
    {
      "gene": "EGFR",
      "variant": "c.2573T>G",
      "cdna_change": "c.2573T>G",
      "protein_change": null,
      "vaf": 45.0,
      "classification": null,
      "hgnc_code": {
        "code": "HGNC:3236",
        "system": "http://www.genenames.org",
        "name": "Epidermal Growth Factor Receptor",
        "chromosome": "7",
        "cancer_types": [
          "NSCLC",
          "Glioblastoma",
          "Colorectal"
        ],
        "actionable": true
      },
      "clinical_annotation": {
        "variant": "EGFR c.2573T>G",
        "actionability": {
          "is_actionable": false,
          "score": 0.0,
          "level": null
        },
        "oncogenicity": {
          "classification": "Unknown",
          "mutation_effect": null
        },
        "therapeutic_options": {
          "fda_approved": [],
          "guideline_recommended": [],
          "investigational": [],
          "resistance": []
        },
        "evidence_sources": [],
        "references": {
          "civic": null,
          "oncokb": "https://www.oncokb.org/gene/EGFR"
        },
        "recommendation": "No high-level evidence for targeted therapy"
      }
    },
    {
      "gene": "EGFR",
      "variant": "c.2369C>T",
      "cdna_change": "c.2369C>T",
      "protein_change": null,
      "vaf": 12.0,
      "classification": null,
      "hgnc_code": {
        "code": "HGNC:3236",
        "system": "http://www.genenames.org",
        "name": "Epidermal Growth Factor Receptor",
        "chromosome": "7",
        "cancer_types": [
          "NSCLC",
          "Glioblastoma",
          "Colorectal"
        ],
        "actionable": true
      },
      "clinical_annotation": {
        "variant": "EGFR c.2369C>T",
        "actionability": {
          "is_actionable": false,
          "score": 0.0,
          "level": null
        },
        "oncogenicity": {
          "classification": "Unknown",
          "mutation_effect": null
        },
        "therapeutic_options": {
          "fda_approved": [],
          "guideline_recommended": [],
          "investigational": [],
          "resistance": []
        },
        "evidence_sources": [],
        "references": {
          "civic": null,
          "oncokb": "https://www.oncokb.org/gene/EGFR"
        },
        "recommendation": "No high-level evidence for targeted therapy"
      }
    },
    {
      "gene": "KRAS",
      "variant": "G12C",
      "cdna_change": null,
      "protein_change": "G12C",
      "vaf": null,
      "classification": null,
      "hgnc_code": {
        "code": "HGNC:6407",
        "system": "http://www.genenames.org",
        "name": "KRAS Proto-Oncogene, GTPase",
        "chromosome": "12",
        "cancer_types": [
          "NSCLC",
          "Colorectal",
          "Pancreatic"
        ],
        "actionable": true
      },
      "clinical_annotation": {
        "variant": "KRAS G12C",
        "actionability": {
          "is_actionable": true,
          "score": 100,
          "level": "LEVEL_1"
        },
        "oncogenicity": {
          "classification": "Oncogenic",
          "mutation_effect": "Gain-of-function"
        },
        "therapeutic_options": {
          "fda_approved": [
            "Adagrasib",
            "Sotorasib"
          ],
          "guideline_recommended": [],
          "investigational": [],
          "resistance": []
        },
        "evidence_sources": [
          "CIViC",
          "OncoKB"
        ],
        "references": {
          "civic": "https://civicdb.org/variants/45",
          "oncokb": "https://www.oncokb.org/gene/KRAS/G12C"
        },
        "recommendation": "FDA-approved targeted therapy available: Adagrasib, Sotorasib"
      }
    },
    {
      "gene": "EGFR",
      "variant": "L858R",
      "cdna_change": null,
      "protein_change": "L858R",
      "vaf": null,
      "classification": null,
      "hgnc_code": {
        "code": "HGNC:3236",
        "system": "http://www.genenames.org",
        "name": "Epidermal Growth Factor Receptor",
        "chromosome": "7",
        "cancer_types": [
          "NSCLC",
          "Glioblastoma",
          "Colorectal"
        ],
        "actionable": true
      },
      "clinical_annotation": {
        "variant": "EGFR L858R",
        "actionability": {
          "is_actionable": true,
          "score": 100,
          "level": "LEVEL_1"
        },
        "oncogenicity": {
          "classification": "Oncogenic",
          "mutation_effect": "Gain-of-function"
        },
        "therapeutic_options": {
          "fda_approved": [
            "Afatinib",
            "Erlotinib",
            "Gefitinib",
            "Osimertinib"
          ],
          "guideline_recommended": [],
          "investigational": [],
          "resistance": []
        },
        "evidence_sources": [
          "CIViC",
          "OncoKB"
        ],
        "references": {
          "civic": "https://civicdb.org/variants/12",
          "oncokb": "https://www.oncokb.org/gene/EGFR/L858R"
        },
        "recommendation": "FDA-approved targeted therapy available: Afatinib, Erlotinib, Gefitinib"
      }
    }
  ],
  "tmb": 6.2,
  "ngs_method": null,
  "quality_metrics": {
    "completeness_pct": 25.0,
    "variants_found": 6,
    "diagnosis_mapped": true,
    "warnings": []
  }
}